Guardant Health and PathGroup Join Forces to Expand Access to FDA-Approved Shield Blood Test for Early Colorectal Cancer Detection Across 25 States in the U.S.
By Team VOH
Guardant Health, a leader in precision oncology, has announced a strategic partnership with PathGroup